Antacid Medications Market Size, Key Manufactures, Cost Structures And Competitors Analysis, 2018-2026
Antacid
Medications Market Overview
Antacids are used to
treat acid reflux that causes heartburn, indigestion, and stomach
upset. They provide quick relief from heartburn, which is a major
symptom of gastroesophageal reflux disease and indigestion. Treatment
with antacids is symptomatic and is usually recommended for minor
symptoms. Antacids include magnesium carbonate, aluminum hydroxide,
and magnesium trisilicate. Some people have reported allergic
reactions to antacids. Antacids with magnesium may cause diarrhea,
while those containing calcium and aluminum may cause constipation.
Long-term use may cause kidney stones and may increase the risk of
contracting osteoporosis. Popular antacid brands include Alka
seltzer, Gelusil, Milk of Magnesia, Maalox, Gaviscon, Mylanta,
Rolaids, and Tums.
Request For
Sample Copy Of This Report:
https://www.coherentmarketinsights.com/insight/request-sample/91
Distribution
channel of Antacids
Antacids are mainly
sold through two distribution channels, namely chemists and
non-chemist. Non-chemists comprise grocers, general stores, and food
stores. Abbott’s Digene and Pfizer’s Gelusil have a doctor
heritage. Eno and Pudin Hara have an ayurvedic base and are available
over the counter and are aiding in growth of the antacid medications
market. Over-the-counter availability of antacids have enabled
individuals to self-medicate their bouts of acid reflux, which can
increase probability of suffering from stroke in the future. Antacids
are available in different forms such as water dissolving tablet,
powder form, and melt-in-mouth granules.
Antacid
medications market taxonomy – Formulation, Drug and Demographic
Antacid medications
market is classified by various ways such as by formulation, drug and
Demographic. On the basis of formulation, the antacid medications
market is classified as tablets, capsules, suspensions, and drops. On
the basis of demographic, antacid medications market is classified as
products for pediatrics and products for adults. On the basis of
drug, antacid medications market is classified as histamine-2 (H2)
blockers, proton pump inhibitor, and pro-motility agents.
Increasing
incidence of acid reflux in North America fueling growth of the
antacid medications market
Increasing trend of
self-medication consequently fuels demand for OTC digestive products
for treatment of gastrointestinal distress. Antacids are used to
neutralize acidity and thus, are expected to lead to rampant increase
in demand for the same in North America due to rising incidence of
gastroesophageal reflux disease (GERD) in the region. According to a
study conducted by American Gastroenterological Association and
published in International Foundation for Functional in February
2016, approximately one-third of the population in U.S. suffers from
GERD. According to a study published in National Center for
Biotechnology Information (NCBI) in June 2014, the range of GERD
prevalence was 18.1%–27.8% in North America, 8.7%–33.1% in the
Middle East, 8.8%–25.9% in Europe, 2.5%–7.8% in East Asia, and
11.6% in Australia. Increasing prevalence of GERD creates a
favorable environment growth of the antacid medications market.
Increasing
self-medication trend driving antacid medications market growth
Increasing
inclination of the populace towards self-medication supplemented by
growing availability of over-the-counter products in convenient to
use sachets is a prevalent trend observed in the market. This trend
is expected to continue over the forecast period, in turn fueling
market growth.
Global
players operating in the antacid medications market
Various companies
manufacture antacids and other products for indigestion. Some of
these are GlaxoSmithKline plc, Dabur India Limited, Abbott
Laboratories, and Pfizer, Inc. Sun Pharma launched an ayurvedic
digestive remedy called Pepmelt to compete with popular antacids such
as Eno (GSK consumer healthcare), Digene (Abbott India), Pudin Hara
(Dabur), and Gelusil (Pfizer). According to 2014 estimates of the
National Institute of Diabetes and Digestive and Kidney Diseases
(NIDDK), approximately 20% of the U.S. population suffered from
gastroesophageal reflux disease, or GERD.
Click To Read
More On Antacid
Medications Market
About
Coherent Market Insights:
Coherent Market Insights is a prominent market research and
consulting firm offering action-ready syndicated research reports,
custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Comments
Post a Comment